On December 2, Gelonghui reported that china resources boya bio-pharmaceutical group (300294.SZ) stated on the investor interaction platform that the company is mainly engaged in the research and development, production, and sales of blood products. Blood products refer to plasma protein products extracted from healthy human plasma through separation and purification methods. The company's products are not related to stem cells.
博雅生物(300294.SZ)：公司产品产品与干细胞无关联
China Resources Boya Bio-Pharmaceutical Group (300294.SZ): The company's products are not related to stem cells.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated